vs
Side-by-side financial comparison of BridgeBio Pharma, Inc. (BBIO) and FTAI Infrastructure Inc. (FIP). Click either name above to swap in a different company.
FTAI Infrastructure Inc. is the larger business by last-quarter revenue ($188.4M vs $154.2M, roughly 1.2× BridgeBio Pharma, Inc.). FTAI Infrastructure Inc. runs the higher net margin — -79.7% vs -126.2%, a 46.5% gap on every dollar of revenue. On growth, BridgeBio Pharma, Inc. posted the faster year-over-year revenue change (2521.2% vs 95.9%).
Brent Saunders is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He founded the special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthet...
FTAI Infrastructure Inc. owns, operates and invests in high-quality critical infrastructure assets across core sectors including transportation logistics, midstream energy, and power generation. It primarily serves North American markets, focusing on assets with stable long-term cash flows, contracted revenue streams, and strong market positions to deliver sustainable returns for stakeholders.
BBIO vs FIP — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $154.2M | $188.4M |
| Net Profit | $-194.6M | $-150.2M |
| Gross Margin | 94.7% | — |
| Operating Margin | -90.5% | — |
| Net Margin | -126.2% | -79.7% |
| Revenue YoY | 2521.2% | 95.9% |
| Net Profit YoY | 27.2% | -387.6% |
| EPS (diluted) | $-1.00 | $-1.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $188.4M | ||
| Q4 25 | $154.2M | $143.5M | ||
| Q3 25 | $120.7M | $140.6M | ||
| Q2 25 | $110.6M | $122.3M | ||
| Q1 25 | $116.6M | $96.2M | ||
| Q4 24 | — | $80.8M | ||
| Q3 24 | — | $83.3M | ||
| Q2 24 | — | $84.9M |
| Q1 26 | — | $-150.2M | ||
| Q4 25 | $-194.6M | $-97.7M | ||
| Q3 25 | $-184.9M | $-104.5M | ||
| Q2 25 | $-183.8M | $-70.0M | ||
| Q1 25 | $-169.6M | $120.2M | ||
| Q4 24 | — | $-124.7M | ||
| Q3 24 | — | $-43.0M | ||
| Q2 24 | — | $-48.1M |
| Q1 26 | — | — | ||
| Q4 25 | 94.7% | — | ||
| Q3 25 | 94.6% | — | ||
| Q2 25 | 96.7% | — | ||
| Q1 25 | 97.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -90.5% | -45.7% | ||
| Q3 25 | -120.3% | -70.8% | ||
| Q2 25 | -121.4% | -56.4% | ||
| Q1 25 | -89.5% | 81.8% | ||
| Q4 24 | — | -152.7% | ||
| Q3 24 | — | -51.7% | ||
| Q2 24 | — | -56.4% |
| Q1 26 | — | -79.7% | ||
| Q4 25 | -126.2% | -68.1% | ||
| Q3 25 | -153.2% | -74.4% | ||
| Q2 25 | -166.2% | -57.2% | ||
| Q1 25 | -145.4% | 125.0% | ||
| Q4 24 | — | -154.4% | ||
| Q3 24 | — | -51.6% | ||
| Q2 24 | — | -56.7% |
| Q1 26 | — | $-1.32 | ||
| Q4 25 | $-1.00 | $-1.04 | ||
| Q3 25 | $-0.95 | $-1.38 | ||
| Q2 25 | $-0.95 | $-0.73 | ||
| Q1 25 | $-0.88 | $0.89 | ||
| Q4 24 | — | $-1.21 | ||
| Q3 24 | — | $-0.45 | ||
| Q2 24 | — | $-0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $570.1M | $37.9M |
| Total DebtLower is stronger | $2.0B | — |
| Stockholders' EquityBook value | $-2.1B | $-122.5K |
| Total Assets | $936.0M | $5.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $37.9M | ||
| Q4 25 | $570.1M | $57.4M | ||
| Q3 25 | $643.0M | $34.7M | ||
| Q2 25 | $756.9M | $33.6M | ||
| Q1 25 | $540.6M | $26.3M | ||
| Q4 24 | — | $27.8M | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $33.1M |
| Q1 26 | — | — | ||
| Q4 25 | $2.0B | $3.8B | ||
| Q3 25 | $2.0B | $3.7B | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.6B |
| Q1 26 | — | $-122.5K | ||
| Q4 25 | $-2.1B | $21.3M | ||
| Q3 25 | $-1.9B | $181.1M | ||
| Q2 25 | $-1.8B | $375.5M | ||
| Q1 25 | $-1.6B | $476.2M | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | $370.8M | ||
| Q2 24 | — | $394.8M |
| Q1 26 | — | $5.7B | ||
| Q4 25 | $936.0M | $5.7B | ||
| Q3 25 | $998.3M | $5.5B | ||
| Q2 25 | $1.1B | $4.4B | ||
| Q1 25 | $881.6M | $4.1B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 176.99× | ||
| Q3 25 | — | 20.59× | ||
| Q2 25 | — | 8.21× | ||
| Q1 25 | — | 5.79× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 4.14× | ||
| Q2 24 | — | 3.94× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-56.4M | $-69.4M |
| Free Cash FlowOCF − Capex | $-56.5M | — |
| FCF MarginFCF / Revenue | -36.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-69.4M | ||
| Q4 25 | $-56.4M | $-2.8M | ||
| Q3 25 | $-109.6M | $-24.4M | ||
| Q2 25 | $-80.7M | $-5.2M | ||
| Q1 25 | $-199.2M | $-85.7M | ||
| Q4 24 | — | $-8.1M | ||
| Q3 24 | — | $14.2M | ||
| Q2 24 | — | $-17.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-56.5M | $-68.6M | ||
| Q3 25 | $-110.0M | $-90.7M | ||
| Q2 25 | $-81.3M | $-87.5M | ||
| Q1 25 | — | $-151.7M | ||
| Q4 24 | — | $-34.3M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $-32.1M |
| Q1 26 | — | — | ||
| Q4 25 | -36.6% | -47.8% | ||
| Q3 25 | -91.2% | -64.5% | ||
| Q2 25 | -73.5% | -71.6% | ||
| Q1 25 | — | -157.7% | ||
| Q4 24 | — | -42.4% | ||
| Q3 24 | — | -14.0% | ||
| Q2 24 | — | -37.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 45.9% | ||
| Q3 25 | 0.4% | 47.2% | ||
| Q2 25 | 0.5% | 67.3% | ||
| Q1 25 | 0.0% | 68.6% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 31.1% | ||
| Q2 24 | — | 17.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
